You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 12, March 23/30, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Viral Infections
 •Pulmonary Diseases, Other
 •Alert me on articles by topic

ABO Blood Group and Susceptibility to Severe Acute Respiratory Syndrome

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: ABO blood group has been reported to influence susceptibility to the Norwalk virus and Helicobacter pylori infections.1-2 The prevalence of H pylori infection in Taiwan is significantly higher in patients with blood group O than in those with other blood groups,3 possibly due to a reduced number of H pylori receptors in persons with group A or group B blood. We studied the relationship between ABO blood group and the development of severe acute respiratory syndrome coronavirus (SARS-CoV) infection in a group of health care workers who were exposed to an index SARS patient and who were not wearing any personal protective equipment.

Methods

The first major SARS outbreak in Hong Kong occurred in March 2003. The index case was a patient who was admitted to Prince of Wales Hospital, a 1000-bed general hospital.4 The patient had been placed in an open ward with 20 other patients because . . . [Full Text of this Article]

Yufeng Cheng, MD, PhD; Gregory Cheng, MD, PhD; C. H. Chui, PhD; F. Y. Lau, PhD
Department of Medicine & Therapeutics

Paul K. S. Chan, MBBS, MSc, MRCPath, FHKCPath
Department of Microbiology

Margaret H. L. Ng, MBChB, MRCPath
Department of Anatomical & Cellular Pathology

Joseph J. Y. Sung, MD, PhD
Department of Medicine & Therapeutics

Raymond S. M. Wong, MBChB, MRCP
raymondwong@cuhk.edu.hk
Department of Medicine & Therapeutics
Chinese University of Hong Kong
Hong Kong, China



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
Guillon et al.
Glycobiology 2008;18:1085-1093.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.